BamSEC and AlphaSense Join Forces
Learn More

Gain Therapeutics Inc. – Indentures

NASDAQ: GANX    
Share price (8/17/26): $2.04    
Market cap (8/17/26): $89.0 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 10-K 6 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Act of 1934 ​
12/34/56
EX-4.3
from 8-K 19 pages Warrant Agent Agreement
12/34/56
EX-4.2
from 8-K 15 pages Common Stock Purchase Warrant Gain Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Gain Therapeutics, Inc
12/34/56
EX-4.6
from S-3 49 pages Gain Therapeutics, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Subordinated Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.5
from S-3 53 pages Gain Therapeutics, Inc., as Issuer and ●, as Trustee Indenture Dated as of ● Senior Debt Securities Cross Reference Sheet1 Between
12/34/56
EX-4.1
from 10-K 6 pages ​ Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Act of 1934 ​
12/34/56
EX-4.2
from 8-K 15 pages Representative’s Purchase Warrant Gain Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 17 pages Pre-Funded Common Stock Purchase Warrant Gain Therapeutics, Inc
12/34/56
EX-4.1
from 10-K 6 pages ​ Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Act of 1934 ​
12/34/56
EX-4.6
from 8-K 18 pages Common Stock Purchase Warrant Gain Therapeutics, Inc
12/34/56
EX-4.5
from 8-K 18 pages Warrant Agent Agreement
12/34/56
EX-4.4
from 8-K 18 pages Pre-Funded Common Stock Purchase Warrant Gain Therapeutics, Inc
12/34/56
EX-4.3
from 8-K 17 pages Underwriter’s Warrant Agreement
12/34/56
EX-4.2
from 8-K 17 pages Common Stock Purchase Warrant Gain Therapeutics, Inc
12/34/56
EX-4.1
from 8-K 18 pages Common Stock Purchase Warrant Gain Therapeutics, Inc
12/34/56
EX-4.8
from S-8 8 pages Gain Therapeutics Inc. Stock Option Grant Notice
12/34/56
EX-4.7
from S-8 5 pages Gain Therapeutics Inc. Rsu Award Grant Notice
12/34/56
EX-4.6
from S-8 33 pages Gain Therapeutics Inc. 2022 Equity Incentive Plan Adopted by the Board of Directors: May 12, 2022 Approved by the Stockholders: June 16, 2022
12/34/56
EX-4.5
from S-8 8 pages Gain Therapeutics Inc. 2021 Inducement Equity Incentive Plan Restricted Stock Unit Award Agreement
12/34/56